LDT (Tyzeka 600 mg)
Generic Name: telbivudine
Pill imprint LDT has been identified as Tyzeka 600 mg.
Tyzeka is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tyzeka 600 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for LDT (Tyzeka 600 mg)
Tyzeka
- Generic Name:
- telbivudine
- Imprint:
-
LDT
- Strength:
- 600 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Corporation
More resources
Tyzeka is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
